Splash Beverage Group (EDVA)
Distributor of Chispo tequila and developer of a licensed cannabinoid epilepsy treatment.
Something off on this page? Send us feedback.
Distributes Chispo tequila through independent distributors while shifting from a former beverage portfolio toward a licensed cannabinoid epilepsy program. U.S. CannEpil commercialization depends on clinical trials, regulatory approval, and its Argent license.
Distributes Chispo, a blue-agave blanco tequila made in Jalisco, Mexico, through independent distributors in certain U.S. states and international markets. Sales are currently concentrated in on-premise hospitality, including Señor Frog's locations in Florida, the Bahamas, and Mexico.
Is shifting from its former multi-brand beverage portfolio toward regulated cannabinoid wellness and pharmaceutical development. Its exclusive worldwide CannEpil license covers a CBD-and-THC formulation for drug-resistant epilepsy, while its Avicanna holding is a minority investment and Medterra remains a proposed transaction.
Commercializing CannEpil in the United States requires clinical trials and a new drug application. Argent is the expected manufacturer and receives a royalty on net revenue, tying the program to clinical, regulatory, financing, and licensor-manufacturer execution.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $242.7K · Total debt $6.4M · Total assets $1.1M · Shareholders' equity −$15.7M
- Revenue
- $0
- Operating income
- −$2.0M
- Net income
- −$2.1M
No dividends on record.
| Institutions | 5.55% | 170.0K shares | |
|---|---|---|---|
| 15 holders · as of Mar 31, 2026 | |||
institutions as of Mar 31, 2026 · holders as of their latest filing
No reliable share count is available for this listing, so stakes are shown as shares, not percentages.
The institutional percentage is the one reported with the filings, not one recomputed on the share count here.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
HRT Financial LPInstitution | — | 134,456 | as of Mar 31, 2026 |
Virtu Financial LLCInstitution | — | 100,185 | as of Mar 31, 2026 |
Summit Trail Advisors, LLCInstitution | — | 100,000 | as of Mar 31, 2026 |
Phraction Management LLCInstitution | — | 70,000 | as of Mar 31, 2026 |
Lifetime Wealth Management P.C.Institution | — | 66,050 | as of Mar 31, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- Diageo (ADR)
Premium tequila portfolio in on-premise and distributor placements.
- Jazz Pharmaceuticals
Approved cannabinoid epilepsy therapy for CannEpil's intended population.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Splash Beverage Group | $0.2468 | +2.28% | $1.5M | — | — | — | +863.8% |
| Diageo (ADR) | $87.24 | +0.48% | $48.26B | 27.8 | — | 2.5 | −1.7% |
| Jazz Pharmaceuticals | $240.72 | −0.31% | $15.17B | 16.5 | 9.6 | 3.3 | +15.6% |
| Median | 22.2 | 9.6 | 2.9 | +6.9% |